Evidence map›Paper›PMID 34431656›Full record

ArticleACS chemical biology2021

A Sort-Seq Approach to the Development of Single Fluorescent Protein Biosensors.

John N Koberstein, Melissa L Stewart, Taylor L Mighell, Chadwick B Smith, Michael S Cohen

Open access · greenAbstract read
In one paragraph

Article in ACS chemical biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Monitoring glycolytic dynamics in single cells using a fluorescent biosensor for fructose 1,6-bisphosphate.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  12. Article
  13. Omics-Driven Biotechnology for Industrial Applications.Frontiers in bioengineering and biotechnology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

John N KobersteinVollum Institute, Oregon Health & Science University, Portland, Oregon 97239, United States.ORCID 0000-0003-0622-5289
Melissa L StewartVollum Institute, Oregon Health & Science University, Portland, Oregon 97239, United States.
Taylor L MighellDepartment of Molecular and Medical Genetics, Oregon Health & Science University, Portland, Oregon 97239, United States.
Chadwick B SmithVollum Institute, Oregon Health & Science University, Portland, Oregon 97239, United States.
Michael S CohenDepartment of Physiology and Pharmacology, Oregon Health & Science University, Portland, Oregon 97239, United States.ORCID 0000-0002-7636-4156
Oregon Health & Science University · US

Funding

Travel Grant PA-18-591T32NS007466 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI Kelly R Monk, Kevin Wright · 1999 to 2026
$7.0M
Monitoring NAD+ levels in aging using a novel genetically-encoded biosensorR01AG055431 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI GOODMAN, RICHARD H. · 2017 to 2020
$1.5M
NIA NIH HHS R01 AG055431NINDS NIH HHS T32 NS007466
6 · The paper itself

Abstract

Motivated by the growing importance of single fluorescent protein biosensors (SFPBs) in biological research and the difficulty in rationally engineering these tools, we sought to increase the rate at which SFPB designs can be optimized. SFPBs generally consist of three components: a circularly permuted fluorescent protein, a ligand-binding domain, and linkers connecting the two domains. In the absence of predictive methods for biosensor engineering, most designs combining these three components will fail to produce allosteric coupling between ligand binding and fluorescence emission. While methods to construct diverse libraries with variation in the site of GFP insertion and linker sequences have been developed, the remaining bottleneck is the ability to test these libraries for functional biosensors. We address this challenge by applying a massively parallel assay termed "sort-seq," which combines binned fluorescence-activated cell sorting, next-generation sequencing, and maximum likelihood estimation to quantify the brightness and dynamic range for many biosensor variants in parallel. We applied this method to two common biosensor optimization tasks: the choice of insertion site and optimization of linker sequences. The sort-seq assay applied to a maltose-binding protein domain-insertion library not only identified previously described high-dynamic-range variants but also discovered new functional insertion sites with diverse properties. A sort-seq assay performed on a pyruvate biosensor linker library expressed in mammalian cell culture identified linker variants with substantially improved dynamic range. Machine learning models trained on the resulting data can predict dynamic range from linker sequences. This high-throughput approach will accelerate the design and optimization of SFPBs, expanding the biosensor toolbox.

Indexed as

Amino Acid SequenceEscherichia coliFlow CytometryGene LibraryGreen Fluorescent ProteinsHigh-Throughput Screening AssaysMachine LearningMaltoseMutant ProteinsProtein BindingProtein DomainsPyruvic AcidSingle Molecule ImagingGreen Fluorescent ProteinsMaltoseMutant ProteinsPyruvic Acid

Identifiers

PMID34431656
PMCPMC9807264
OpenAlexW3194571942

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.